Summary:
- This article discusses the development of a new gene therapy technique that could potentially treat a rare genetic disorder called Duchenne muscular dystrophy (DMD).
- The researchers used a novel approach involving CRISPR-Cas9 gene editing to correct the genetic mutation responsible for DMD in a mouse model.
- The results show that this gene therapy was able to restore muscle function and improve the overall health of the mice, suggesting it could be a promising treatment for patients with this devastating condition.